← Home

BRN

Tech / AI / DefenseDOWNTREND

$0.115

as of 2026-07-27

Who's been buying — 30 days

net $, conviction-weighted
RetailRetail · context+$1.9M
WAWealth & advisers+$934k
NIBInvestment banks+$849k
MMMarket makers+$287k
ResResource specialists+$262k

5d return

-11.5%

20d return

-25.8%

60d return

-25.8%

RSI 14

11.1

vs 52w high

-53.1%

vs 52w low

+0.0%

SMA 20

Below

SMA 50

Below

Price · Volume · Broker flow
Markers = announcements (red triangle = price-sensitive). Volume amber = ≥2× ADV spike. Flow bars stacked per broker group. Flow lags T+3.
Loading chart…
Closest correlates
Pearson r on log returns, window: 42d
  • HHRr=0.62, window: 42d
  • PDNr=0.61, window: 42d
  • NXTr=0.53, window: 42d
  • TM1r=0.47, window: 42d
  • EVRr=0.45, window: 42d
Announcements — last 30 days
  • BrainChip has reached a critical inflection point: receipt of first AKD1500 production batch (2,000 units from ~60,000 target run) validates manufacturing readiness, though lower-than-expected yields are being investigated. Concurrent IP licensing milestone (RTL delivery to EDGEAI) and expiration of LDA put option reduce near-term financing friction, positioning the company for 2H 2026 commercial shipments across defense/industrial verticals.

  • BrainChip's LDA Put Option facility has expired cleanly; the A$1M failure fee was satisfied through collateral share sales without tapping company cash, and ~6M remaining shares will be liquidated orderly by LDA over coming weeks with net proceeds returned to BRN. This marks a clean deleveraging event that preserves cash and removes a legacy financing overhang.